Summary
Laminin is a basement membrane glycoprotein whose expression has been widely related to cancer progression. Laminin production by primary breast carcinomas was investigated using immunohistochemistry on archival specimens from a retrospective series with long term follow-up. Laminin production was found to be independent of the clinical and pathological variables analyzed, whereas a statistically significant direct association with the expression of the laminin receptor and a negative association with the differentiation-related antigen Ca-MBr8 were observed. Survival analysis indicated that laminin positivity by itself has no prognostic significance. However, when analyzed together with the laminin receptor expression, laminin was associated with a good prognosis in receptor-negative tumors and with the worst prognosis in receptor-positive tumors.
This is a preview of subscription content, log in via an institution to check access.
References
Timpl R, Engel J, Martin GR: Laminin: a multifunctional protein of basement membranes. Trends Biochem 8: 207–209, 1983
Kleinman HK, Cannon FB, Laurie JR, Hassell JR, Aumailley M, Terranova VP, Martin GR, Dubois-Dalco M: Biological activities of laminin. J Cell Biochem 27: 317–325, 1985
Castronovo V: Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 13: 1–30, 1993
Ruoslahti E: Integrins. J Clin Invest 87: 1–5, 1991
Rao CN, Barsky SH, Terranova VP, Liotta LA: Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 111: 804–808, 1983
Varani J, Lovett EJ, McCoy JP, Shibata S, Maddose DE, Goldstein IJ, Wicha M: Differential expression of a lamininlike substance by high and low metastatic tumor cells. Am J Pathol 111: 27–34, 1983
Turpeenniemi HT, Thorgeirsson UP, Rao CN, Liotta LA: Laminin increases the release of type IV collagenase from malignant cells. J Biol Chem 261: 1883–1889, 1986
Castronovo B, Parent P, Foidart JM, Heynen E, Goffinet G, Lambotte R, Mahieu P: Perfusion of human umbilical veins. A new approach to study the interactions of circulating malignant cells with vascular wall and their modulation. Invasion Metastasis 8: 332–350, 1988
Vollmers HP, Imhof BA, Braun S, Waller CA, Schirrmacher V, Birchmeier W: Monoclonal antibodies which prevent experimental lung metastasis in a murine model. FEBS Lett 172: 17–20, 1984
Albrechtsen R, Nielsen M, Wewer U, Engvall E, Ruoslahti E: Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 41: 5076–5081, 1981
D'Ardenne AJ, Kirkpatrick P, Wells CA, Davies JD: Laminin and fibronectin in adenoid cystic carcinoma. J Clin Pathol 39: 138–144, 1986
D'Ardenne AJ, Richman PI, Horton MA, MCaulay AE, Jordan S: Co-ordinate expression of the alpha-6 integrin laminin receptor subunit and laminin in breast cancer. J Pathol 165: 213–220, 1991
Terranova VP, Rao CN, Kalebic T, Margulies IM, Liotta LA: Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 80: 444–448, 1983
Castronovo V, Taraboletti G, Liotta LA, Sobel ME: Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst 81: 781–788, 1989
Marques AL, Franco ELF, Torloni H, Brentani MM, Da Silva-Neto JB, Brentani RR: Independent prognostic value of laminin expression in breast cancer survival. Cancer Res 50: 1479–1483, 1990
Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, Garbisa S, Liotta LA, Grigioni WF: Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 48: 529–532, 1991
Martignone S, Ménard S, Bufalino R, Cascinelli N, Pellegrini R, Tagliabue E, Andreola S, Rilke F, Colnaghi MI: Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 85: 398–402, 1993
Mariani-Costantini R, Barbanti P, Colnaghi MI, Ménard S, Clemente C, Rilke F: Reactivity of a monoclonal antibody with tissues and tumors from human breast: Immunohistochemical localization of a new antigen and clinico-pathologic correlations. Am J Pathol 115: 47–56, 1984
Mastroianni A, Invernizzi L, Tagliabue E, Fassina G, Albini A, Ménard S, Colnaghi MI: Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane. Tumor Biol 14: 279–287, 1993
Facheris P, Perrone F, Ménard S, Andreola S, Bazzini P, Bufalino R, Canevari S, Cascinelli N, Colzani E, Di Fronzo G, Colnaghi MI: Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma. Br J Cancer 65: 466–470, 1992
Martignone S, Pellegrini R, Villa E, Tandon NN, Mastroianni A, Tagliabue E, Ménard S, Colnaghi MI: Characterization of two monoclonal antibodies directed against the 67 KDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metast 10: 379–386, 1992
Barsky SH, Rao CN, Williams JE, Liotta LA: Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 74: 843–848, 1984
Malinoff HL, McCoy JP, Varani J, Wicha MS: Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin. Int J Cancer 33: 651–655, 1984
Taraboletti G, Belotti D, Giavazzi R, Sobel ME, Castronovo V: Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: Attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J Natl Cancer Inst 85: 235–240, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pellegrini, R., Martignone, S., Tagliabue, E. et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res Tr 35, 195–199 (1995). https://doi.org/10.1007/BF00668209
Issue Date:
DOI: https://doi.org/10.1007/BF00668209